TrialCardiovascular drugs and therapy2025

Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials.

Robert S Rosenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.